- Home
- EPWK vs BRTX Comparison
EPWK vs BRTX Comparison
Compare EPWK & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- BRTX
- Stock Information
- Founded
- EPWK 2011
- BRTX 1997
- Country
- EPWK China
- BRTX United States
- Employees
- EPWK N/A
- BRTX N/A
- Industry
- EPWK
- BRTX Managed Health Care
- Sector
- EPWK
- BRTX Health Care
- Exchange
- EPWK Nasdaq
- BRTX Nasdaq
- Market Cap
- EPWK 11.0M
- BRTX 12.5M
- IPO Year
- EPWK 2025
- BRTX N/A
- Fundamental
- Price
- EPWK $0.46
- BRTX $1.41
- Analyst Decision
- EPWK
- BRTX Strong Buy
- Analyst Count
- EPWK 0
- BRTX 1
- Target Price
- EPWK N/A
- BRTX $18.00
- AVG Volume (30 Days)
- EPWK 643.6K
- BRTX 106.5K
- Earning Date
- EPWK 05-27-2025
- BRTX 08-12-2025
- Dividend Yield
- EPWK N/A
- BRTX N/A
- EPS Growth
- EPWK N/A
- BRTX N/A
- EPS
- EPWK N/A
- BRTX N/A
- Revenue
- EPWK $20,164,008.00
- BRTX $391,000.00
- Revenue This Year
- EPWK N/A
- BRTX $216.71
- Revenue Next Year
- EPWK N/A
- BRTX $60.63
- P/E Ratio
- EPWK N/A
- BRTX N/A
- Revenue Growth
- EPWK 10.25
- BRTX 161.54
- 52 Week Low
- EPWK $0.41
- BRTX $1.21
- 52 Week High
- EPWK $26.00
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- BRTX 34.84
- Support Level
- EPWK N/A
- BRTX $1.42
- Resistance Level
- EPWK N/A
- BRTX $1.67
- Average True Range (ATR)
- EPWK 0.00
- BRTX 0.11
- MACD
- EPWK 0.00
- BRTX -0.02
- Stochastic Oscillator
- EPWK 0.00
- BRTX 5.13
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.